Effect of ferric citrate hydrate on FGF23 and PTH levels in patients with non-dialysis-dependent chronic kidney disease with normophosphatemia and iron deficiency

ConclusionIron-based phosphate binder did not decrease serum FGF23 levels, but decreased serum PTH levels.
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research